1. Home
  2. DTST vs UBX Comparison

DTST vs UBX Comparison

Compare DTST & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTST
  • UBX
  • Stock Information
  • Founded
  • DTST 2001
  • UBX 2009
  • Country
  • DTST United States
  • UBX United States
  • Employees
  • DTST N/A
  • UBX N/A
  • Industry
  • DTST EDP Services
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTST Technology
  • UBX Health Care
  • Exchange
  • DTST Nasdaq
  • UBX Nasdaq
  • Market Cap
  • DTST 32.7M
  • UBX 38.6M
  • IPO Year
  • DTST N/A
  • UBX 2018
  • Fundamental
  • Price
  • DTST $4.05
  • UBX $1.94
  • Analyst Decision
  • DTST
  • UBX Strong Buy
  • Analyst Count
  • DTST 0
  • UBX 2
  • Target Price
  • DTST N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • DTST 46.0K
  • UBX 330.9K
  • Earning Date
  • DTST 03-27-2025
  • UBX 11-04-2024
  • Dividend Yield
  • DTST N/A
  • UBX N/A
  • EPS Growth
  • DTST N/A
  • UBX N/A
  • EPS
  • DTST 0.02
  • UBX N/A
  • Revenue
  • DTST $25,143,911.00
  • UBX N/A
  • Revenue This Year
  • DTST $2.57
  • UBX N/A
  • Revenue Next Year
  • DTST $11.16
  • UBX $33.62
  • P/E Ratio
  • DTST $201.93
  • UBX N/A
  • Revenue Growth
  • DTST 1.64
  • UBX N/A
  • 52 Week Low
  • DTST $3.24
  • UBX $0.94
  • 52 Week High
  • DTST $8.00
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • DTST 40.40
  • UBX 50.03
  • Support Level
  • DTST $4.12
  • UBX $1.81
  • Resistance Level
  • DTST $4.25
  • UBX $2.39
  • Average True Range (ATR)
  • DTST 0.22
  • UBX 0.27
  • MACD
  • DTST -0.05
  • UBX -0.06
  • Stochastic Oscillator
  • DTST 5.32
  • UBX 12.50

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: